N@N

NTLS, ISPH, ANAD, LAB, AMAG, FSP Expected To Be Down After Next Earnings Releases

May 2, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, May 3rd 2011 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and 6 Consecutive Days earnings reports. NTELOS HOLDINGS CORP (NASDAQ:NTLS), INSPIRE PHARMACEUTICALS INC (NASDAQ:ISPH), ANADIGICS INC (NASDAQ:ANAD), LABRANCHE & CO INC (NYSE:LAB), AMAG PHARMACEUTICALS INC (NASDAQ:AMAG), FRANKLIN STREET PROPERTIES C (AMEX:FSP) are all expected to be Down After their earnings are released Tuesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Tuesday:

     Symbol     Company                             # of Reports            Quarter     Release Time
     NTLS       NTELOS HOLDINGS CORP                6 Quarter               Q1          After
     ISPH       INSPIRE PHARMACEUTICALS INC         6 Quarter               Q1          Before
     ANAD       ANADIGICS INC                       6 Quarter               Q1          Before
     LAB        LABRANCHE & CO INC                  6 Quarter               Q1          Before
     AMAG       AMAG PHARMACEUTICALS INC            12 Quarter              Q1          After
     FSP        FRANKLIN STREET PROPERTIES C        12 Quarter              Q1          After

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

NTELOS HOLDINGS CORP (NASDAQ:NTLS) - NTELOS Holdings Corp. provides integrated communications services primarily in Virginia, West Virginia, and Tennessee. The company offers wireless and wireline communications products and services to businesses, telecommunications carriers, and residential customers under the NTELOS brand name. It offers a range of voice services, such as primary rate ISDN services and long distance service, as well as customer calling features, including call waiting, caller ID, and voice mail. The company also offers broadband and data services, including high-speed DSL access, broadband XL, video, metro Ethernet, IP services, high-capacity private line service, Web hosting, and local dial-up Internet access. It markets and sells local and long distance, voice, and data services to business customers through its competitive local exchange carrier and Internet service provider operations. As of December 31, 2009, the companys wireless retail business had approximately 438,500 NTELOS-branded subscribers; and served customers with approximately 49,700 CLEC access line connections. It also operated approximately 23,500 broadband access connections and approximately 38,200 RLEC telephone access lines; and owned a 4,700 route-mile regional fiber optic network. The company has a strategic network alliance with Sprint Nextel. NTELOS Holdings Corp. was founded in 1897 and is headquartered in Waynesboro, Virginia.

INSPIRE PHARMACEUTICALS INC (NASDAQ:ISPH) - Inspire Pharmaceuticals, Inc., a biopharmaceutical company, focuses on researching, developing, and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. The company offers AzaSite, an azithromycin ophthalmic solution and topical anti-infective for the treatment of bacterial conjunctivitis; Elestat, an epinastine HCl ophthalmic solution and topical antihistamine for the prevention of ocular itching associated with allergic conjunctivitis; and Restasis, a cyclosporine ophthalmic emulsion for the treatment of dry eye disease. Its product candidates in clinical development include Denufosol tetrasodium for the treatment of cystic fibrosis, which is under phase III clinical trial; Prolacria for the treatment of dry eye disease, which is under phase III clinical trial; AzaSite for the treatment of blepharitis that is under phase II clinical trial; and Glaucoma product candidates, which are in phase I clinical trial. The company has an agreements with Allergan, Inc. to co-promote Elestat in the United States, as well as to develop and commercialize Restasis and Prolacria; a license agreement with InSite Vision Incorporated to commercialize AzaSite, as well as other topical anti-infective products containing azithromycin used in the treatment of human ocular or ophthalmic indications primarily in the United States and Canada; and a development, license, and supply agreement with Santen Pharmaceutical Co., Ltd. for the development of diquafosol tetrasodium for the therapeutic treatment of ocular surface diseases in Asia. Inspire Pharmaceuticals, Inc. was founded in 1993 and is based in Durham, North Carolina.

ANADIGICS INC (NASDAQ:ANAD) - ANADIGICS, Inc. provides semiconductor solutions to the broadband wireless and wireline communications markets. Its products include power amplifiers, tuner integrated circuits, active splitters, line amplifiers, and other components. The company designs, develops, and manufactures radio frequency integrated circuits primarily using gallium arsenide compound semiconductor substrates with various process technologies, metal semiconductor field effect transistors, pseudomorphic high electron mobility transistors, and heterojunction bipolar transistors. It offers third generation products that use the wideband code-division multiple access (W-CDMA) and enhanced data rates for global system for mobile communication evolution (EDGE) standards, as well as combinations of W-CDMA and EDGE platforms (WEDGE); third generation (3.5G) products that use the high speed packet access (HSPA) and Evolution Data Optimized (EVDO) standards; fourth generation (4G) products for worldwide interoperability for microwave access; wireless fidelity products; cable television (CATV) cable modem and set-top box products; CATV infrastructure products; and Fiber-To-The-Premises products. The company sells its products through direct sales, as well as through independent manufacturers representatives and distributors. It has a strategic agreement with WIN Semiconductors Corp. The company was founded in 1984 and is headquartered in Warren, New Jersey.

LABRANCHE & CO INC (NYSE:LAB) - LaBranche & Co Inc., through its subsidiaries, operates as a registered broker-dealer. It operates as market-maker in options, futures, and exchange-traded funds (ETF) traded on various exchanges. The company operates in two segments, Market-Making and Institutional Brokerage. The Market-Making segment operates as a market maker in equity, index and ETF options, ETFs, and futures on the NYSE Amex Exchange, the NYSE Arca Exchange, the New York Board of Trade, the Philadelphia Stock Exchange, and the Chicago Board Options Exchange; broker-dealer registered with the United Kingdoms Financial Securities Authority; market maker for ETFs traded on the London Stock Exchange, and the Euroex and Euronext Exchanges; broker-dealer with Hong Kongs Securities and Futures Commission; and market maker for ETFs in Hong Kong, as well as engages in hedging transactions in Asia. The Institutional Brokerage segment provides securities execution, fixed income, and professional trading brokerage services to institutional investors and professional traders; and operates as a market maker in over-the-counter, bulletin board, and pink sheet securities. This segment also engages in agency business that trades high-yield debt for its institutional customers, as well as acts as an agent in transactions related to leveraged loans and commercial loans. The company was founded in 1924 and is based in New York, New York.

AMAG PHARMACEUTICALS INC (NASDAQ:AMAG) - AMAG Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic iron compounds to treat iron deficiency anemia (IDA) in the United States, Europe, and Japan. It also provides novel imaging agents to aid in the diagnosis of cancer and cardiovascular diseases. It offers Feraheme, an iron replacement therapeutic for the treatment of IDA in adult patients with chronic kidney disease; and GastroMARK used for delineating the bowel in magnetic resonance imaging (MRI). The company is also developing Feraheme, which is in Phase II clinical trials for use as a vascular-enhanced MRI agent for the assessment of peripheral arterial disease. AMAG Pharmaceuticals has collaborative agreements with 3SBio Inc. for the development and commercialization of Feraheme as an IV iron replacement therapeutic agent in China; Guerbet S.A; Takeda Pharmaceutical Co. Ltd.; and Covidien for marketing GastroMARK in the United States, Canada, and Mexico. The company was founded in 1981 and is based in Lexington, Massachusetts.

FRANKLIN STREET PROPERTIES C (AMEX:FSP) - Franklin Street Properties Corp. provides real estate and investment banking/investment services in the United States. The companys Real Estate Operations segment involves in real estate rental operations, leasing, and secured financing of real estate for interim acquisition or other property financing, as well as provides asset management, property management, property acquisitions, dispositions, and development. As of December 31, 2008, it owned and operated a portfolio of 29 real estate properties, which include 28 office buildings and 1 industrial use property. The companys Investment Banking/Investment Services segment involves in the structuring of real estate investments and broker/dealer services that include the organization of Sponsored real estate investment trusts (REITs), the acquisition and development of real estate on behalf of Sponsored REITs, and the raising of capital to equitize the Sponsored REITs through sale of preferred stock in private placements. This segment offers investment banking/investment services primarily to institutions and high net-worth individuals. The company has elected to be taxed as a REIT under the Internal Revenue Code of 1986. As a REIT, it would not be subject to federal income tax, provided it distributes at least 90% of its taxable income to its shareholders. Franklin Street Properties Corp. was founded in 1981 and is headquartered in Wakefield, Massachusetts.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641